Literature DB >> 1362369

Relationship between iron status and chronic akathisia in an in-patient population with chronic schizophrenia.

T R Barnes1, S M Halstead, P W Little.   

Abstract

Iron status and akathisia were assessed in 105 long-stay in-patients who fulfilled DSM-III-R criteria for schizophrenia, all but three of whom were receiving antipsychotic medication. Chronic akathisia was diagnosed in 23% and pseudoakathisia in 20%. No significant correlation was found between serum iron concentration and the severity of akathisia. There was no significant difference in serum iron concentration between patients with chronic akathisia and those without. However, serum iron and percentage saturation were significantly raised in patients with pseudoakathisia compared with patients with chronic akathisia, and tended to be higher than in patients with akathisia. These findings do not support an association between low serum iron and chronic akathisia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362369     DOI: 10.1192/bjp.161.6.791

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

1.  Improvement in neuroleptic-induced akathisia with intravenous iron treatment in a patient with iron deficiency.

Authors:  Paul E Cotter; Shaun T O'Keeffe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.

Authors:  Maria Juncal-Ruiz; Mariluz Ramirez-Bonilla; Jorge Gomez-Arnau; Victor Ortiz-Garcia de la Foz; Paula Suarez-Pinilla; Obdulia Martinez-Garcia; Karl David Neergaard; Rafael Tabares-Seisdedos; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2017-05-31       Impact factor: 4.530

4.  Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.

Authors:  Bunta Yoshimura; Kojiro Sato; Shinji Sakamoto; Masaru Tsukahara; Yusaku Yoshimura; Ryuhei So
Journal:  Psychopharmacology (Berl)       Date:  2018-11-15       Impact factor: 4.530

5.  Iron status, movement disorders, and acute phase response in elderly psychiatric patients.

Authors:  A J Treloar; M A Crook; P Tutt; D P White; M P Philpot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

6.  Neuroleptic malignant syndrome and catatonia. A report of three cases.

Authors:  M Raja; M C Altavista; S Cavallari; L Lubich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

7.  Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder.

Authors:  Sung-Wan Kim; Robert Stewart; Woo-Young Park; Min Jhon; Ju-Yeon Lee; Seon-Young Kim; Jae-Min Kim; Paul Amminger; Young-Chul Chung; Jin-Sang Yoon
Journal:  Nutrients       Date:  2018-11-08       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.